An intranasal vaccine protects 40 people against different strains of avian flu.

An experimental intranasal vaccine has been shown to generate a broad immune response against multiple strains of H5N1 avian influenza in a small clinical trial conducted on 40 volunteers.

The initial results, published in the journal ' Nature Communications ', highlight the potential of strategies for ...